Development and Validation of a Stability-Indicating LC-UV Method for Simultaneous Determination of Ketotifen and Cetirizine in Pharmaceutical Dosage Forms
Abstract
Purpose: To develop and validate stability-indicating reversed phase high performance liquid chromatographic method for simultaneous determination of ketotifen fumarate and cetirizine dihydrochloride in solid dosage forms.
Methods: Chromatographic separation was achieved on Grace Smart C18 column (250 × 4.6 mm, 5 μm) using an isocratic mobile phase that consisted of acetonitrile and 10 mM disodium hydrogen phosphate buffer (pH 6.5) in a ratio of 45:55 % v/v at a flow rate of 1 mL/min. Detection was carried out at 230 nm. Salbutamol sulphate was used as an internal standard. The drugs were exposed to hydrolytic (acid and alkaline), oxidative, reductive and neutral stress conditions, and the stressed samples analyzed by the proposed method. Validation of the method was carried out as per International Conference of Harmonization (ICH) guidelines.
Results: The retention time for ketotifen, salbutamol and cetirizine was 2.05, 5.37 and 6.77 min, respectively. In stress studies, it was observed as cetirizine was more labile in acidic, oxidative and neutral conditions than ketotifen. Both the drugs were found comparatively stable in alkaline, neutral condition and labile in reductive condition. The method was linear in the concentration range of 1 - 30 μg/mL and 10 - 300 μg/mL for ketotifen and cetirizine, respectively.
Conclusion: The developed method is specific and stability-indicating as no interfering peaks of degradants and excipients were observed. Thus, the method is suitable for application in the simultaneous quality control of both drugs.
Keywords: Ketotifen, Cetirizine, Stability indicating method, Stressed conditions, Validation
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
